Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2020-09-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
独立董事关于第五届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the fourth meeting of the fifth board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It specifically addresses the approval and legality of a restricted stock incentive plan granted on September 28, 2020. The content focuses on governance, compliance with laws and regulations, and the board's decision-making process regarding stock incentives. There is no financial data, earnings information, or report publication announcement. The document is a formal board/management related announcement concerning corporate governance and board decisions on stock incentives, fitting the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2020-09-28 Chinese
关于医疗器械经营许可证续期的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the renewal of their medical device business license. It includes details such as the license number, issuing authority, validity period, and scope of business. The document is short (1106 characters) and does not contain financial data, management discussion, or regulatory certifications. It is not a financial report, audit, or management change announcement. Instead, it is a regulatory announcement about a business license renewal, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-09-21 Chinese
2020年第二次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2020 second extraordinary general meeting (临时股东大会) of Guangzhou Yangpu Medical Technology Co., Ltd. It details the legality and validity of the meeting process and voting outcomes. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its resolutions. It is not an announcement of voting results per se, but a legal opinion on the meeting's conduct and results. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal procedural filing related to a shareholder meeting, not the meeting materials themselves (AGM-R), nor the voting results announcement (DVA). The document length is under 5,000 characters, but it is a substantive legal opinion, not a mere announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-09-17 Chinese
2020年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2020 second extraordinary general meeting of shareholders of Guangzhou Yangpu Medical Technology Co., Ltd. It details the meeting attendance, voting results on specific proposals, and includes a legal opinion confirming the validity of the meeting and voting procedures. There are no financial statements or detailed financial data presented, nor is this a full annual or interim report. The document is primarily a formal disclosure of shareholder meeting decisions and voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2441 characters, which is relatively short and consistent with a voting results announcement rather than a full report or presentation.
2020-09-17 Chinese
关于2020年限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告
Regulatory Filings Classification · 95% confidence The document is a self-inspection report regarding insider trading and stock transactions by insiders and incentive plan participants related to a 2020 restricted stock incentive plan. It includes detailed stock transaction data for insiders and incentive recipients during a specified period and concludes no insider trading occurred. The document is a regulatory announcement about compliance and insider trading checks related to a stock incentive plan, not a financial report, earnings release, or management report. It does not contain financial statements or earnings data, nor is it a meeting presentation or voting result. It fits best as a Regulatory Filing (RNS) because it is a compliance disclosure related to insider trading and stock incentive plans, which does not fall under other specific categories.
2020-09-17 Chinese
监事会关于2020年限制性股票激励计划激励对象名单的审核意见及公示情况说明
Regulatory Filings Classification · 95% confidence The document is a public announcement by the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. regarding the review and public disclosure of the list of incentive recipients under the company's 2020 restricted stock incentive plan. It includes details about the verification process, compliance with relevant laws and regulations, and confirmation that the incentive recipients meet the required qualifications. The document does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is an official announcement related to a stock incentive plan and the verification of the incentive recipients. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories such as Capital/Financing Update or Management Reports.
2020-09-14 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.